MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AxoGen Accounts Receivables 2011-2026 | AXGN
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables AxoGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.2 M | 24.1 M | 25.1 M | 22.2 M | 18.2 M | 17.6 M | 16.9 M | 15.3 M | 11.1 M | 8.05 M | 4.78 M | 2.87 M | 1.89 M | 1.05 M | 798 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.2 M | 798 K | 13.1 M |
Quarterly Accounts Receivables AxoGen
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 M | 26.3 M | 24.1 M | 24.6 M | 25.2 M | 24.2 M | 25.1 M | 23.3 M | 21.6 M | 22.3 M | 22.2 M | 21.4 M | - | 18.6 M | 18.2 M | 18.6 M | 18.2 M | 19.8 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 8.05 M | 8.05 M | 8.05 M | 8.05 M | 4.78 M | 4.78 M | 4.78 M | 4.78 M | 2.87 M | 2.87 M | 2.87 M | 2.87 M | 1.89 M | 1.89 M | 1.89 M | 1.89 M | 1.05 M | 1.05 M | 1.05 M | 1.05 M | 798 K | 798 K | 798 K | 798 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28 M | 798 K | 12.3 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B |  USA |
 |
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
272 M | $ 9.38 | -1.78 % | $ 722 M | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
Inogen
INGN
|
38.9 M | $ 6.5 | 1.25 % | $ 173 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
Stryker Corporation
SYK
|
4.04 B | $ 332.68 | 1.57 % | $ 127 B | USA |
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
11.7 M | $ 9.13 | -0.76 % | $ 327 M | USA |
 |
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | USA |
 |
Tandem Diabetes Care
TNDM
|
165 M | $ 23.32 | -3.87 % | $ 1.59 B | USA |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
Outset Medical
OM
|
28.3 M | $ 3.52 | -0.28 % | $ 53.5 K | USA |
 |
PAVmed
PAVM
|
61 K | $ 8.94 | -3.87 % | $ 64.7 M | USA |
 |
CONMED Corporation
CNMD
|
248 M | $ 36.64 | -1.19 % | $ 1.14 B | USA |
 |
Electromed
ELMD
|
24.7 M | $ 24.45 | -0.85 % | $ 207 M | USA |
 |
Viemed Healthcare
VMD
|
25.6 M | $ 9.22 | -1.39 % | $ 359 M | USA |
 |
Cytosorbents Corporation
CTSO
|
7.32 M | $ 0.6 | -10.61 % | $ 32.7 M | USA |
 |
Aethlon Medical
AEMD
|
128 K | $ 2.27 | -2.16 % | $ 3.54 M | USA |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
216 M | $ 63.65 | 0.55 % | $ 3.47 B |  Britain |
 |
InspireMD
NSPR
|
2.17 M | $ 1.73 | -2.26 % | $ 111 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
371 M | $ 11.41 | 0.18 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
190 M | $ 336.42 | 0.04 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
75.7 M | $ 3.94 | -3.9 % | $ 582 M | USA |
 |
TELA Bio
TELA
|
10.3 M | $ 0.75 | 8.11 % | $ 35.2 M | USA |
 |
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | USA |
 |
Myomo
MYO
|
4.1 M | $ 0.68 | -2.2 % | $ 28.5 M | USA |
 |
NanoVibronix
NAOV
|
98 K | - | - | $ 1.08 M | USA |
 |
Beyond Air
XAIR
|
710 K | $ 0.69 | -6.74 % | $ 46.7 M | USA |
 |
Inspire Medical Systems
INSP
|
120 M | $ 50.45 | -1.87 % | $ 1.48 B | USA |
 |
Xtant Medical Holdings
XTNT
|
20.7 M | $ 0.57 | 0.53 % | $ 76.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
12.1 M | $ 1.24 | -4.62 % | $ 50.5 M | USA |
 |
Varex Imaging Corporation
VREX
|
157 M | $ 10.78 | 0.84 % | $ 446 M | USA |
 |
Cutera
CUTR
|
43.1 M | - | -10.19 % | $ 1.99 M | USA |